Sonothera's ultrasound gene therapy delivery, a new Alzheimer's drug controversy, and more biotech news from The Readout ...
Health officials have identified lettuce from Mexico served at Taco Bell locations across five U.S. states as a source of the ...
Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis line ...
A Senate vote to halt a Medicare pilot that uses artificial intelligence to approve or deny care failed along party lines on ...
MDCalc is launching a quality-rating system for the more than 800 clinical calculators used to assess disease risk, ...
Sonothera is developing a new way to deliver genes into cells that, if borne out, could have a big impact on muscular ...
Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Turmoil at the American ...
CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient ...
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health ...
Eli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its ...
A brain-computer interface helped restore movement and sensation in a 48-year old man with quadriplegia, researchers say.
Managing risk factors is the key to further progress in reducing deaths from coronary artery disease, a new study finds.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results